VIRTUE clinical trial opens to primary immunodeficiency patients across the U.S.
The VIRTUE Trial is a Phase IV clinical trial evaluating patient satisfaction and annual rate of serious bacterial infections using Vivaglobin subcutaneous administration for one year. Patients will self-administer the medication and assess overall health-related quality of life, comparing it to previous intravenous treatment experience.